What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Neuroscience
- Neurotransmitter
Anthony H. Dickenson mostly deals with Nociception, Neuroscience, Neuropathic pain, Pharmacology and Spinal cord.
His Nociception research is multidisciplinary, incorporating elements of Anesthesia and Endocrinology, Central nervous system, Inhibitory postsynaptic potential.
His work carried out in the field of Neuroscience brings together such families of science as NMDA receptor, Hyperalgesia and Nociceptor.
The concepts of his Neuropathic pain study are interwoven with issues in Peripheral neuropathy, Gabapentin, Physical therapy, Chronic pain and Allodynia.
The various areas that he examines in his Pharmacology study include Capsaicin, TRPV1, Opioid and Opiate.
Anthony H. Dickenson interconnects Excitatory postsynaptic potential and Premovement neuronal activity in the investigation of issues within Spinal cord.
His most cited work include:
- Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurones following c fibre stimulation. (767 citations)
- The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways (691 citations)
- Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain (546 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Neuroscience, Nociception, Neuropathic pain, Pharmacology and Spinal cord.
His study in Neuroscience is interdisciplinary in nature, drawing from both NMDA receptor and Hyperalgesia, Allodynia.
His Nociception research is multidisciplinary, relying on both Anesthesia and Endocrinology, Stimulation, Central nervous system.
His Neuropathic pain study integrates concerns from other disciplines, such as Peripheral neuropathy, Analgesic, Nerve injury, Gabapentin and Chronic pain.
The Pharmacology study combines topics in areas such as Agonist, -Naloxone, Antagonist, Opioid and Nociceptor.
His research integrates issues of Anatomy, Receptor, Excitatory postsynaptic potential, Premovement neuronal activity and Brainstem in his study of Spinal cord.
He most often published in these fields:
- Neuroscience (43.18%)
- Nociception (41.44%)
- Neuropathic pain (31.76%)
What were the highlights of his more recent work (between 2013-2021)?
- Neuropathic pain (31.76%)
- Neuroscience (43.18%)
- Pharmacology (28.78%)
In recent papers he was focusing on the following fields of study:
Anthony H. Dickenson mainly investigates Neuropathic pain, Neuroscience, Pharmacology, Nociception and Chronic pain.
His Neuropathic pain study is concerned with the larger field of Anesthesia.
As a part of the same scientific study, Anthony H. Dickenson usually deals with the Anesthesia, concentrating on Electrophysiology and frequently concerns with Voltage-dependent calcium channel.
His Pharmacology study combines topics from a wide range of disciplines, such as Calcium channel, Monoamine neurotransmitter, Antagonist and Opioid.
The study incorporates disciplines such as Stimulation and Central nervous system in addition to Nociception.
His work in Spinal cord addresses subjects such as Peripheral nerve injury, which are connected to disciplines such as Allodynia.
Between 2013 and 2021, his most popular works were:
- Pain and Nociception: Mechanisms of Cancer-Induced Bone Pain (178 citations)
- Assessment and manifestation of central sensitisation across different chronic pain conditions. (174 citations)
- Osteoarthritis pain: nociceptive or neuropathic? (121 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Neurotransmitter
- Neuron
His main research concerns Neuropathic pain, Neuroscience, Pharmacology, Nociception and Hyperalgesia.
Anthony H. Dickenson has included themes like Gabapentin, Analgesic, Chronic pain and Calcium channel in his Neuropathic pain study.
His Neuroscience research includes themes of Monoamine neurotransmitter and Peripheral nerve injury.
His Pharmacology study incorporates themes from Agonist and Stimulation.
His Nociception research incorporates elements of Bone pain, Physical therapy, Cancer pain and Bioinformatics.
His Hyperalgesia research includes elements of Threshold of pain and Opioid.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
